laboratoire.jpg
 

Break through.

To bring forward new medicines and technologies

 

We are focused

 

On bringing breakthrough medicines and technologies to patients.  Based in Paris and Boston, iXLife Capital identifies, evaluates, invests in, and supports biotech companies that take creative approaches to developing important new therapies and devices for cancer, neurologic, and other diseases and conditions.

 

Managing Partner / Jean-Pierre Kinet
Partner / Albert Hsia
Partner / Marina Iche
Venture Partner / Samuel Levy

 

 
dendritic_cells.jpg

iXLife 1